Four failure patterns, and how to design them out

Why Data & AI Portfolios Stall in Regulated Environments

A portfolio governance model for regulated environments: intake funnel, decision rights, benefit ownership, and the move into business-as-usual

Read more
filters
AI Transformation
Portfolio Governance
The Context

Most data and AI portfolios do not fail because the technology does not work. They fail because no forum was ever obliged to choose.Trade-offs surfaced, and nobody had to resolve them.

Capacity is the binding constraint. Good ideas are plentiful; what runs short is the specific people who can move an idea through a regulated organisation and into stable operations – the ones who clear data access, validation evidence, and privacy review.

Approve work without accounting for that, and the portfolio becomes over-committed. Nothing fails outright. Initiatives drift, teams fragment, and the slippage becomes visible only once it is too late to trade anything off.

While this is written from a pharma and life sciences PoV, the patterns recur wherever validation, privacy, and quality sit on the critical path.

The Context

Most data and AI portfolios do not fail because the technology does not work. They fail because no forum was ever obliged to choose.Trade-offs surfaced, and nobody had to resolve them.

Capacity is the binding constraint. Good ideas are plentiful; what runs short is the specific people who can move an idea through a regulated organisation and into stable operations – the ones who clear data access, validation evidence, and privacy review.

Approve work without accounting for that, and the portfolio becomes over-committed. Nothing fails outright. Initiatives drift, teams fragment, and the slippage becomes visible only once it is too late to trade anything off.

While this is written from a pharma and life sciences PoV, the patterns recur wherever validation, privacy, and quality sit on the critical path.

The Context

Most data and AI portfolios do not fail because the technology does not work. They fail because no forum was ever obliged to choose.Trade-offs surfaced, and nobody had to resolve them.

Capacity is the binding constraint. Good ideas are plentiful; what runs short is the specific people who can move an idea through a regulated organisation and into stable operations – the ones who clear data access, validation evidence, and privacy review.

Approve work without accounting for that, and the portfolio becomes over-committed. Nothing fails outright. Initiatives drift, teams fragment, and the slippage becomes visible only once it is too late to trade anything off.

While this is written from a pharma and life sciences PoV, the patterns recur wherever validation, privacy, and quality sit on the critical path.

The Context

Most data and AI portfolios do not fail because the technology does not work. They fail because no forum was ever obliged to choose.Trade-offs surfaced, and nobody had to resolve them.

Capacity is the binding constraint. Good ideas are plentiful; what runs short is the specific people who can move an idea through a regulated organisation and into stable operations – the ones who clear data access, validation evidence, and privacy review.

Approve work without accounting for that, and the portfolio becomes over-committed. Nothing fails outright. Initiatives drift, teams fragment, and the slippage becomes visible only once it is too late to trade anything off.

While this is written from a pharma and life sciences PoV, the patterns recur wherever validation, privacy, and quality sit on the critical path.

The Context

Most data and AI portfolios do not fail because the technology does not work. They fail because no forum was ever obliged to choose.Trade-offs surfaced, and nobody had to resolve them.

Capacity is the binding constraint. Good ideas are plentiful; what runs short is the specific people who can move an idea through a regulated organisation and into stable operations – the ones who clear data access, validation evidence, and privacy review.

Approve work without accounting for that, and the portfolio becomes over-committed. Nothing fails outright. Initiatives drift, teams fragment, and the slippage becomes visible only once it is too late to trade anything off.

While this is written from a pharma and life sciences PoV, the patterns recur wherever validation, privacy, and quality sit on the critical path.

The Context

Four Patterns We See Repeatedly
  1. Three initiatives approved in a quarter, all depending on the same two data engineers and the same validation queue. Each approval was sound on its own merits. The portfolio was never actually decided.
  2. Green for six consecutive weeks, then a single-step slip. Nobody is rewarded for escalating early, so the status holds while the assumptions underneath it drift.
  3. A solution the users call a success, the people funding it call unproven.
  4. Monitoring in place and alerts accumulating unread. Accountability for the outcome, the service, and the data definitions all defaulted to the last project team standing.
Four Patterns We See Repeatedly
  1. Three initiatives approved in a quarter, all depending on the same two data engineers and the same validation queue. Each approval was sound on its own merits. The portfolio was never actually decided.
  2. Green for six consecutive weeks, then a single-step slip. Nobody is rewarded for escalating early, so the status holds while the assumptions underneath it drift.
  3. A solution the users call a success, the people funding it call unproven.
  4. Monitoring in place and alerts accumulating unread. Accountability for the outcome, the service, and the data definitions all defaulted to the last project team standing.
Four Patterns We See Repeatedly
  1. Three initiatives approved in a quarter, all depending on the same two data engineers and the same validation queue. Each approval was sound on its own merits. The portfolio was never actually decided.
  2. Green for six consecutive weeks, then a single-step slip. Nobody is rewarded for escalating early, so the status holds while the assumptions underneath it drift.
  3. A solution the users call a success, the people funding it call unproven.
  4. Monitoring in place and alerts accumulating unread. Accountability for the outcome, the service, and the data definitions all defaulted to the last project team standing.

Four Patterns We See Repeatedly

  1. Three initiatives approved in a quarter, all depending on the same two data engineers and the same validation queue. Each approval was sound on its own merits. The portfolio was never actually decided.
  2. Green for six consecutive weeks, then a single-step slip. Nobody is rewarded for escalating early, so the status holds while the assumptions underneath it drift.
  3. A solution the users call a success, the people funding it call unproven.
  4. Monitoring in place and alerts accumulating unread. Accountability for the outcome, the service, and the data definitions all defaulted to the last project team standing.

Four Patterns We See Repeatedly

  1. Three initiatives approved in a quarter, all depending on the same two data engineers and the same validation queue. Each approval was sound on its own merits. The portfolio was never actually decided.
  2. Green for six consecutive weeks, then a single-step slip. Nobody is rewarded for escalating early, so the status holds while the assumptions underneath it drift.
  3. A solution the users call a success, the people funding it call unproven.
  4. Monitoring in place and alerts accumulating unread. Accountability for the outcome, the service, and the data definitions all defaulted to the last project team standing.

Four Patterns We See Repeatedly

What You'll Discover in the Whitepaper
  1. A two-lane intake funnel, with a fast-track for mandatory work
  2. Decision rights split across Decision Board, Steering Committee, and operational reporting
  3. Three separate funding models for different business realities
  4. A benefit framework covering financial, capacity, and risk/quality outcomes, with worked kill triggers
  5. A five-point handover checklist for the move into business-as-usual
What You'll Discover in the Whitepaper
  1. A two-lane intake funnel, with a fast-track for mandatory work
  2. Decision rights split across Decision Board, Steering Committee, and operational reporting
  3. Three separate funding models for different business realities
  4. A benefit framework covering financial, capacity, and risk/quality outcomes, with worked kill triggers
  5. A five-point handover checklist for the move into business-as-usual
What You'll Discover in the Whitepaper
  1. A two-lane intake funnel, with a fast-track for mandatory work
  2. Decision rights split across Decision Board, Steering Committee, and operational reporting
  3. Three separate funding models for different business realities
  4. A benefit framework covering financial, capacity, and risk/quality outcomes, with worked kill triggers
  5. A five-point handover checklist for the move into business-as-usual

What You'll Discover in the Whitepaper

  1. A two-lane intake funnel, with a fast-track for mandatory work
  2. Decision rights split across Decision Board, Steering Committee, and operational reporting
  3. Three separate funding models for different business realities
  4. A benefit framework covering financial, capacity, and risk/quality outcomes, with worked kill triggers
  5. A five-point handover checklist for the move into business-as-usual

What You'll Discover in the Whitepaper

  1. A two-lane intake funnel, with a fast-track for mandatory work
  2. Decision rights split across Decision Board, Steering Committee, and operational reporting
  3. Three separate funding models for different business realities
  4. A benefit framework covering financial, capacity, and risk/quality outcomes, with worked kill triggers
  5. A five-point handover checklist for the move into business-as-usual

What You'll Discover in the Whitepaper

Why It Matters

All of these concepts are familiar, and most portfolios already run two or three of them well. The difficulty is that the value sits in the sequence. Intake decides what enters. Governance decides what stops. The value framework supplies evidence for both. The handover decides who is still accountable when that evidence arrives. Break the chain at any point, and the portfolio quietly reverts to drift.

Why It Matters

All of these concepts are familiar, and most portfolios already run two or three of them well. The difficulty is that the value sits in the sequence. Intake decides what enters. Governance decides what stops. The value framework supplies evidence for both. The handover decides who is still accountable when that evidence arrives. Break the chain at any point, and the portfolio quietly reverts to drift.

Why It Matters

All of these concepts are familiar, and most portfolios already run two or three of them well. The difficulty is that the value sits in the sequence. Intake decides what enters. Governance decides what stops. The value framework supplies evidence for both. The handover decides who is still accountable when that evidence arrives. Break the chain at any point, and the portfolio quietly reverts to drift.

Why It Matters

All of these concepts are familiar, and most portfolios already run two or three of them well. The difficulty is that the value sits in the sequence. Intake decides what enters. Governance decides what stops. The value framework supplies evidence for both. The handover decides who is still accountable when that evidence arrives. Break the chain at any point, and the portfolio quietly reverts to drift.

Why It Matters

All of these concepts are familiar, and most portfolios already run two or three of them well. The difficulty is that the value sits in the sequence. Intake decides what enters. Governance decides what stops. The value framework supplies evidence for both. The handover decides who is still accountable when that evidence arrives. Break the chain at any point, and the portfolio quietly reverts to drift.

Why It Matters

Whitepaper

The whitepaper breaks down the full governance model: intake and prioritization criteria, decision rights, funding models, a value framework covering financial, capacity, and risk outcomes, and the kill triggers that let leaders stop work without stigma.

Curious how this applies to your own portfolio?

Reach out to our team - we're happy to talk it through. We've worked with organizations on these same governance gaps in data and AI portfolios, and can help you spot where yours might be exposed.

Manager
Silas Faurschou

Manager
Silas Faurschou
Silas Faurschou
This is the default text value
Head of Strategy & Transformation
Dan Nielsen

Head of Strategy & Transformation
Dan Nielsen
Dan Nielsen
This is the default text value
filters
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Why Data & AI Portfolios Stall in Regulated Environments

A portfolio governance model for regulated environments: intake funnel, decision rights, benefit ownership, and the move into business-as-usual

Click to read more
Portfolio Governance
Four failure patterns, and how to design them out
Four failure patterns, and how to design them out
AI Transformation
Portfolio Governance
Assessing Market Opportunity at the Speed the Market Actually Moves

In the full article, we break down the two-level framework for assessing market opportunity, and how agentic AI fits into the process.

Click to read more
Early Pipeline Opportunity Assessment
How agentic AI turns market signals into a portfolio bet you can defend
How agentic AI turns market signals into a portfolio bet you can defend
Market & Competitive Intelligence
Rethinking Data Governance as a Business-Led Discipline

In this article, we outline why effective data governance starts with ownership, not tools - and how organizations can build the structures that make data trustworthy and scalable.

Click to read more
Data Governance
Rethinking Data Governance as a Business-Led Discipline
Rethinking Data Governance as a Business-Led Discipline
AI Transformation
The New Era of Life Sciences Will Be Won on Forecasting Excellence

In this article, we explore why the blockbuster era is giving way to a more fragmented, competitive landscape - and how machine learning is changing the way life science companies predict erosion, time investments, and launch with precision.

Click to read more
Drivers-Based ML forecasting
The New Era of Life Sciences Will Be Won on Forecasting Excellence
The New Era of Life Sciences  Will Be Won on Forecasting Excellence
Forecasting & Scenario Planning